International Journal of Cardiology · 2022 · 37 citations · 32 references
MedicineCardiologyEndocrinologyClinical CardiologyDiabetologyGood Clinical PracticeCardiovascular DiseaseDiabetes ControlDiabetes ManagementDiabetes MellitusGlucagon-like Peptide-1 Receptor AgonistsGlycemic ControlCardiovascular Outcome TrialsGlucagon Receptor AgonismGlucagon Receptor AgonistsGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide 1 SignalingGlucagon-like Peptide-1 Receptor Signaling
32
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +17
Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text
Medicine, Cardiology, Pharmacology +17